AGO1 and hepatocellular carcinoma: Chen et al.37,38,] found that AGO1 may inhibit the expression and function of vascular endothelial growth factor in human umbilical vein endothelial cells (HUVEC), and AGO1 was a marker for better OS and disease-free survival in HCC.